News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine     3/4/2015
Takeda (TKPYY) Promotes Christophe Weber to CEO     3/4/2015
Valeant (VRX) Starts Chopping Dendreon (DNDN) Employees     3/3/2015
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO     3/3/2015
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million     3/3/2015
CALBIO15: Johnson & Johnson (JNJ) Unveils New Innovation Center, Looks to Spark Creative Revolution in the Bay: Exec     3/3/2015
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences     3/3/2015
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey     3/3/2015
SoCal Biotech AtheroNova (AHRO) and its Subsidiary File for Chapter 11     3/3/2015
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged     3/3/2015
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business     3/3/2015
CALBIO15: Genomics Need to Bridge Gap Between Medicine and Science, Says Panel     3/3/2015
CALBIO2015: "Health is the New Asset Class," Says Former Pfizer (PFE) Exec, With Daily Breakthroughs Coloring Investment     3/3/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel     3/2/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/2/2015

News from Around the Web
Ten Great Companies For Women In 2015; Who Made It?     3/3/2015
Finally! Average Penis Size For Men Revealed, King's College London Study     3/3/2015
Coffee Prevents Clogged Arteries And Heart Attacks, Kangbuk Samsung Hospital Study     3/3/2015
Peanut Eaters May Live a Longer Life, Vanderbilt University Study     3/3/2015
Tomatoes, Watermelon, And Papaya May Lower Cancer Risk In Women, Wayne State University Study     3/3/2015
Mutation May Cause Early Loss Of Sperm Supply, Brown University Study     3/3/2015
Nice To Sniff You: Handshakes May Engage Our Sense Of Smell, Weizmann Institute of Science Study     3/3/2015
BPA Exposure Linked To Autism, Rowan University Study     3/3/2015
Licorice Manufacturers Encouraged To State Daily Limit Of Consumption, Pediatric Neurology Reveals     3/3/2015
Autistic Man Who Grew 46DD Breasts Wins $2.5 Million Drug Suit     3/2/2015
Treadmill Performance Predicts Risk Of Death, Johns Hopkins University Study     3/2/2015
Britain's Secret Science Powerhouse     3/2/2015
Shake It Off? Not So Easy For People With Depression, University of Michigan Medical School Study     3/2/2015
Your Brain Knows Your Next Move Before You Do, Howard Hughes Medical Institute Study     3/2/2015
First World War Explosive Could Reverse Diabetes, Yale University Study     3/2/2015

Press Releases
Blueprint Medicines Strikes $265 Million Deal With Alexion Pharmaceuticals Inc. (ALXN)     3/3/2015
Pfizer (PFE) Receives European Approval For New Indication For Prevenar 13 For Prevention Of Vaccine-Type Pneumococcal Pneumonia In Adults     3/3/2015
Hutchison Chi-Med To File For Approval Of Two Cancer Drugs In 2016     3/3/2015
ThromboGenics NV (TBGNF) Receives Positive CHMP Opinion For Ready Diluted Formulation Of JETREA     3/3/2015
Delcath Systems, Inc. (DCTH) Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal     3/3/2015
CEL-SCI (CVM) Reports 2nd Consecutive Month Of Record Patient Enrollment In 2015 For Its Phase III Head And Neck Cancer Trial     3/3/2015
Drug Approved In Pivotal Studies Using DSG, Inc.’s Fully Electronic Source Data     3/3/2015
Soligenix (SNGX) Announces Positive Recommendation By Data Review Committee On Its Phase 2 Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients     3/3/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Primary Peritoneal Cancer     3/3/2015
Aquinox Pharmaceuticals (AQXP) Completes Enrollment In The Phase II LEADERSHIP Trial Of AQX-1125 In Bladder Pain Syndrome/Interstitial Cystitis     3/3/2015
Biota Pharmaceuticals, Inc. (BOTA) Commences Dosing In Vapendavir SPIRITUS Phase IIb Trial     3/3/2015
Prima Biomed (PRR.AX) To Prioritize Immuno-Oncology Programs Targeting Immune Checkpoint LAG-3     3/3/2015
GlycoMimetics, Inc. (GLYC) Announces Publication Of Phase 2 Data For Rivipansel In Sickle Cell Disease     3/3/2015
Vince & Associates Clinical Research Completes CymaBay Therapeutics’ Clinical Trial Of Arhalofenate In Combination With Febuxostat     3/3/2015
Melior Pharmaceuticals Initiates Phase 2 Study With MLR-1023 For Type 2 Diabetes     3/3/2015
Adamis Pharmaceuticals (ADMP) Announces Positive Pharmacokinetic Study Results For Its Dry Powder Inhaler Product     3/3/2015
MyoKardia Announces Initiation Of Phase 1 Clinical Study Of MYK-461 For Hypertrophic Cardiomyopathy     3/3/2015
Cerulean Pharma Inc. (CERU) Establishes Clinical Collaboration With The GOG Foundation To Study CRLX101 In Combination With Weekly Paclitaxel In Relapsed Ovarian Cancer     3/3/2015
Epizyme (EPZM) Announces Presentation Of Data From Phase 1 Study Of EZH2 Inhibitor EPZ-6438 (E7438)     3/3/2015
Rutgers Cancer Institute Of New Jersey Starts ONC201 Clinical Trials     3/3/2015
Momenta Pharmaceuticals, Inc. (MNTA) Announces Publication Revealing Development Of A Novel Process To Generate High-Quality Hyper-Sialylated IVIg Drug Candidate In PNAS     3/3/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation     3/3/2015
BioLife Solutions, Inc. (BLFS.OB) CryoStor Cell Freeze Media Used In Mayo Clinic Safety And Feasibility Study Of Umbilical Cord Blood-Derived Cells For Pediatric Cardiac Regeneration     3/3/2015
Probiodrug AG Release: Data On Glutaminyl Cyclases (Qcs) In Its Relation To Alzheimer’s Disease (AD) Published In Acta Neuropathologica     3/3/2015
Procter & Gamble (PG) Release: 22 Percent Of Young Adult Americans (Age 18-34) Struggle To Fall Asleep More Often On Sunday Night     3/3/2015
Fluoride Action Network Release: New US Study Links Fluoridation To ADHD     3/3/2015
Breast Cancer Study Compares DeNovo Sciences CTC Platform With Cell Search     3/3/2015
The T.J. Martell Foundation Announces Discovery Of Gene Identified As A "Master Regulator" That Will Have A Major Impact On The Development Of Treatments For Prostate Cancer     3/3/2015
VWR, Inc. Announces Expansion Of Distribution Agreement With New England Biolabs, Inc.     3/3/2015
Pulmokine Receives $1 Million Investment From Broadview Ventures To Advance PAH Candidate Into First Clinical Trial     3/3/2015
Islet Sciences Enters Into Exclusive License Agreement For Phase 2 SGLT2 Inhibitor Remogliflozin Etabonate     3/3/2015
Fidelta Achieves Milestone In Collaboration With LEO Pharma     3/3/2015
Genedata Biologics Licensed By Pfizer (PFE)     3/3/2015
Regenicin (RGIN) Receives $2.3 Million In Final Payment From Amarantus     3/3/2015
Exostar & DocuSign Partner to Help Life Sciences and Healthcare Organizations Go 100% Digital     3/3/2015
ISA Pharmaceuticals Signs R&D Agreement With Shin Nippon Biomedical Laboratories     3/3/2015
New Projects For Image Interpretation And Management In Clinical Trials Totaling €1.53M For MEDIAN Technologies     3/3/2015
Cure SMA Announces $315,000 Grant To California Institute Of Biomedical Research     3/3/2015
VLP Therapeutics Wins The 2015 Life Sciences Impact Grant Award From The Montgomery County Department Of Economic Development     3/3/2015
Department Of Defense Supports Neumedicines Inc. With Groundbreaking Grant For Surgical Site Infection Therapy     3/3/2015
CRF Health Patient-Centric Ecoa Solution To Support Flexibility And Compliance In Global Diabetes Trials     3/3/2015
Regen BioPharma Files Patent Application For Treatment Of Myelodysplastic Syndrome Utilizing Gene Silencing Therapy     3/3/2015
Amgen (AMGN) Announces Launch Of New Neulasta (Pegfilgrastim) Delivery Kit     3/3/2015
Cleveland Biolabs Inc. (CBLI) And Incuron Announce Growth Of Curaxin CBL0137 Patent Portfolio With U.S. Composition Of Matter Patent     3/3/2015
Prostate Cancer Research Foundation Switzerland Release: Innovative App Determines Prostate Cancer Risk Level     3/3/2015
Coronado Biosciences (CNDO) Closes $10 Million Private Placement Financing     3/3/2015
Rheumatology Research Foundation Receives $1 Million Donation For Physician-Driven Medical Research     3/3/2015
BioGenerator Leads Investment In AgTech Company, Apse     3/3/2015
Vascular Pharmaceuticals Completes $9 Million Expansion Of Series A Financing     3/3/2015
Actavis (ACT) Announces Closing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN)     3/3/2015
Xencor Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock     3/3/2015
Mylan Inc. (MYL) Files Annual Report On Form 10-K For Year Ended Dec. 31, 2014     3/3/2015
Lion Biotechnologies, Inc. Announces Closing Of Underwritten Public Offering Of Common Stock And Full Exercise Of The Underwriters' Option To Purchase Additional Shares     3/3/2015
Curis, Inc. (CRIS) Announces Closing Of Public Offering Of Common Stock     3/3/2015
Akorn, Inc. (AKN) Announces Filing Extension For Form 10-K     3/3/2015
Tesaro, Inc. (TSRO) Announces Proposed Public Offering Of Common Stock     3/3/2015
Aviva Plc And Aviva Investors Global Services Limited Provide Notification Of A 5.02% Shareholding In Ablynx (ABLYF)     3/3/2015
Verona Pharma (VRP.L) Release: Trading and Development Programme Update     3/3/2015
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Fourth Quarter And Full Year 2014 Financial Results     3/3/2015
DURECT Corporation (DRRX) Announces Epigenomic Regulator Program Including A New NAFLD/NASH And Acute Organ Injury Product Candidate In Development     3/3/2015
Roche (RHHBY) Annual General Meeting 2015     3/3/2015
Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner     3/3/2015
Chrono Therapeutics, Inc. Receives Investment From Rock Health To Advance Smartstoptm Smoking Cessation Technology     3/3/2015
Company Profile For APCER Pharma Solutions, Inc.     3/3/2015
Bristol-Myers Squibb (BMY) Announces Dividend     3/3/2015
Nordic Nanovector - Recommendation Of The Nomination Committee     3/3/2015
Frost & Sullivan Release: Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments     3/3/2015
Mapi Incorporates Strategic Regulatory Services To Support Life-Science Product Commercialization And Health Research     3/3/2015
PTC Therapeutics (PTCT) Announces Translarna Access Program In Duchenne Muscular Dystrophy For Siblings Of Patients Participating In PTC Clinical Trials     3/3/2015
Maverix Biomics Provides Analytic Support To Rare Genomics Institute Competition To Accelerate Personalized Disease Research     3/3/2015
CryoPort, Inc. Expands Support Of Fred Hutchinson Cancer Research Center's Clinical Research Division     3/3/2015
ISIS Services, LLC Announces Corporate Name Change To PMI Preclinical     3/3/2015
Cellceutix (CTIX) To Expand Its Skin Product Pipeline     3/3/2015
Easton Pharmaceuticals (OP: EAPH) Provides Update On The AMFIL Grozone Technology For The Medical Marijuana Industry And Moves Towards Implementation Within Medicated Markets California Operations     3/3/2015
BioAmber Inc. Begins Commissioning Of Sarnia Commercial Plant     3/3/2015
Peak Pharmaceuticals Updates Research And Commercial Activities For Q1     3/3/2015
Mylan N.V. And Mylan Inc. (MYL) Announce Commencement Of Consent Solicitations For Mylan Inc.'s Notes     3/3/2015
Rho Experts Discussing The New FDA Guidance On Data Standards During Free Webinar     3/3/2015
Cannabis Science Inc. Release: CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist     3/3/2015
Nutter McClennen & Fish, LLP Continues To Expand In Biotech And Pharma IP     3/3/2015
BioArbitrage Releaase: Fund Targets $200 Million For Investment In Rare Disease Therapies     3/3/2015
Phenomenex, Inc. Adds Tube Formats To Novum Synthetic Sorbent Line For Simplified Liquid Extraction (SLE)     3/3/2015
Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Eli Lilly (LLY) For Development As A Personalized Medicine     3/3/2015
PDL BioPharma, Inc. (PDLI) Announces Dismissal Of Third And Final Shareholder Lawsuit     3/3/2015
CompleWare Launches Newest Version Of CompleClinical With Integrated Interactive Web Response System (IWRS) Functionality     3/3/2015
Archerdx Improves Speed Of Genome Sequencing Analysis And Assay Design With New Versions Of Its Archer Suite Of Bioinformatics Software     3/3/2015
Bio-Rad Laboratories, Inc. (BIO) Adds New PrimePCR Products For Droplet Digital PCR (ddPCR)     3/3/2015
Bristol-Myers Squibb (BMY) Announces Dividend     3/3/2015
Clinigen Group Plc Release: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m     3/3/2015
Clinigen Group Plc: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m     3/3/2015
DURECT Corporation (DRRX) Announces Fourth Quarter 2014 Financial Results And Update Of Programs     3/3/2015
Halozyme Therapeutics, Inc. (HALO) Reports Fourth Quarter And Full Year 2014 Financial Results     3/3/2015
IGI Laboratories, Inc. Announces Fourth Quarter And Year End 2014 Results     3/3/2015
Intrexon Corporation Announces Fourth Quarter And Full Year 2014 Financial Results     3/3/2015
INSYS Therapeutics Reports Fourth Quarter And Year End 2014 Results     3/3/2015
Ipsen (IPN.PA)’s 2014 Results and 2015 Financial Objectives     3/3/2015
Kindred Bio (KIN) To Announce Fourth Quarter And Year-End 2014 Financial Results     3/3/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Announces 2014 Operating Results     3/3/2015
Mylan Inc. (MYL) Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% To $1.05 And Full Year Adjusted Diluted EPS Up 23% To $3.56     3/3/2015
NeoStem, Inc. Announces 2014 Year-End Financial Results And Provides Corporate Update     3/3/2015
Ocera Therapeutics, Inc. (OCRX) To Announce Fourth Quarter And Full Year 2014 Financial Results     3/3/2015
Oncothyreon Inc. (ONTY) Announces Full Year And Fourth Quarter 2014 Financial Results Conference Call     3/3/2015
OncoMed Pharmaceuticals, Inc. (OMED) To Report Full Year And Fourth Quarter 2014 Financial Results On Thursday, March 12, 2015     3/3/2015
Puma Biotechnology (PBYI) Reports Fourth Quarter And Full Year 2014 Financial Results     3/3/2015
ReVance Therapeutics, Inc. (RVNC) Releases Fourth Quarter And Full Year 2014 Financial Results And Reiterates 2015 Outlook     3/3/2015
Rigel (RIGL) Announces Fourth Quarter And Year End 2014 Financial Results     3/3/2015
TONIX Pharmaceuticals, Inc. (TNXP) Reports Fourth Quarter And Full Year 2014 Financial Results     3/3/2015
Threshold Pharmaceuticals, Inc. (THLD) Reports Fourth Quarter And Year End 2014 Financial And Operational Results     3/3/2015
Zogenix, Inc. (ZGNX) Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2014 Financial Results     3/3/2015
Jim Van Heusden Appointed CEO Of Karolinska Development AB     3/3/2015
PhaseBio Pharmaceuticals, Inc. Announces Expansion Of Leadership Team     3/3/2015
Adaptive Biotechnologies Adds Chad Cohen, Zillow Group CFO, To Board Of Directors     3/3/2015
XOMA (US) LLC (XOMA) Announces Retirement Of Fred Kurland And Appointment Of Thomas Burns As Chief Financial Officer     3/3/2015
ChromaDex, Inc. Appoints Former Nestle Executive, Steve Allen, As Chairman     3/3/2015
Fate Therapeutics (FATE) Expands And Strengthens Leadership Team     3/3/2015
Atara Biotherapeutics (ATRA) Names David A. Carmel As Head Of Immunotherapy     3/3/2015
Oncothyreon Inc. (ONTY) Announces Appointment Of Steven P. James To Board Of Directors     3/3/2015
Researchers At Henry Ford Hospital Propose Thymosin Beta 4 As Novel Way To Treat Neural Injury And Neurodegenerative Diseases     3/3/2015
Generous Donors, Corporate Partners And Celebrities Help Propel St. Jude Children's Research Hospital Thanks And Giving Campaign Past $100 Million For Second Consecutive Year     3/3/2015
Surpass, Inc. Establishes A Surpass Innovation Award To Support Early-Stage Medtech Innovation Within University of California, San Francisco (UCSF)'s Clinical And Translational Science Institute     3/3/2015
Celltex Therapeutics Corporation Release: Texas Woman Finds Answer For MS In Her Own Stem Cells     3/3/2015
Veloxis Pharmaceuticals A/S (VELO) Publishes Annual Report 2014     3/3/2015
NYU Langone Medical Center Release: Don't Let Daylight Savings Disrupt Your Child's Sleep     3/3/2015
Suzhou's Innovent Biologics: Interview With CEO Michael Yu     3/3/2015
Linguamatics Ltd Named In KMWorld's 2015 List Of "100 Companies That Matter In Knowledge Management" For A Second Year     3/3/2015
PSI CRO Recognized For Excellence In Clinical Research     3/3/2015
Chemical Heritage Foundation Release: Phillip Sharp To Receive 2015 Othmer Gold Medal     3/3/2015
Rare Genomics Institute To Award More Than $600,000 Worth Of Research For Rare Diseases     3/3/2015
Cardinal Health (CAH) Named One Of The "Top 50 Companies For Executive Women" By NAFE     3/3/2015
Frost & Sullivan Applauds Neopeutics' Commitment To Accelerating The Delivery Of New Nature-Based Pharmaceuticals And Therapeutics     3/3/2015
The Children's Hospital of Philadelphia's Dr. Adzick Honored For Pioneering Fetal Surgery Research     3/3/2015
Frost & Sullivan Release: 2015 Manufacturing Leadership Award Winners Announced     3/3/2015
Harrington Discovery Institute At University Hospitals Increases Support Of National Award     3/3/2015
Prime Therapeutics Receives PBMI's 2015 Rx Innovation Award     3/3/2015
ORYX To Present At Sachs European Life Science CEO Forum And Exhibition     3/3/2015
Progenics Pharmaceuticals, Inc. (PGNX) Announces Presentation At ENDO 2015     3/3/2015
RedHill Biopharma Ltd. (RDHL) To Present At Bio-Europe Spring 2015 International Partnering Conference     3/3/2015
MediciNova, Inc. Release: MN-166 (Ibudilast) Effects In Opioid Dependence Selected For Presentation At The 77th Annual Meeting Of The College On Problems Of Drug Dependence In Phoenix, Arizona     3/3/2015
Amgen (AMGN) Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data     3/3/2015
Dr. Carlos Buesa, ORYZON Genomics CEO, To Be A Keynote Speaker At The 15th Annual Global Discovery-Summit 2015 In Lisbon, Portugal     3/3/2015
Opko Health, Inc. (OPK) Release: Twelve Months Data Supporting Once-Weekly Dosing Of Hgh-CTP In Growth Hormone Deficient Pediatric Population To Be Presented At ENDO 2015 Conference     3/3/2015
Rosa & Co. Announces Two Poster Presentations At The American Society For Clinical Pharmacology And Therapeutics 2015 Annual Meeting     3/3/2015
Shanghai UBM Sinoexpo International Exhibition Co., Ltd. Release: 15th Anniversary, Be Part Of Chinese Pharma Dream     3/3/2015
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At JDRF TypeOneNation Research Summit     3/3/2015
RedHill Biopharma Ltd. (RDHL) To Present At VirtualInvestorConferences.com Online Event On March 5, 2015     3/3/2015
Gilead (GILD) To Present At The Cowen and Company 35th Annual Health Care Conference On Tuesday, March 3     3/3/2015
Aerie Pharmaceuticals, Inc. (AERI) To Participate In Two Investor Conferences In March     3/3/2015
Atterocor Announces Data Presentations At ENDO 2015     3/3/2015
Ohr Pharmaceutical (OHRP) To Present At The 35th Annual Cowen and Company Health Care Conference     3/3/2015
Celldex (CLDX) Announces Upcoming Presentation At The Cowen and Company 35th Annual Health Care Conference     3/3/2015
Cytori Therapeutics, Inc. (CYTX)To Provide Corporate Update At Cowen and Company 35th Annual Health Care Conference     3/3/2015
Pernix Therapeutics, Inc. (PTX) To Present At The Cowen and Company Health Care Conference In Boston, MA     3/3/2015
Quotient Limited (QTNTU) To Participate In Cowen and Company 35th Annual Health Care Conference     3/3/2015
Zosano Pharma, Inc. To Present At The 27th Annual ROTH Conference     3/3/2015
Galectin Therapeutics To Present At The 27th Annual ROTH Conference     3/3/2015
Peregrine Pharmaceuticals, Inc. (PPHM) To Present At The 27th Annual ROTH Conference     3/3/2015
Affimed Therapeutics AG (AFMD) To Present At The 27th Annual ROTH Conference     3/3/2015
Galena Biopharma  (GALE) To Present At The 27th Annual ROTH Conference     3/3/2015
Anavex (AVXL) To Present At 27th Annual ROTH Conference On March 11th     3/3/2015
RedHill Biopharma Ltd. (RDHL) To Present At The 27th Annual ROTH Conference     3/3/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Webcast Of Its Presentation At The 27th Annual ROTH Conference     3/3/2015
Codexis, Inc. (CDXS) To Present At ROTH Conference     3/3/2015
Alcobra (ADHD) To Present At 27th Annual ROTH Conference     3/3/2015
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At ROTH Conference On March 10th     3/3/2015
Titan Pharmaceuticals (TTP) To Present At 27th Annual ROTH Conference     3/3/2015
ContraFect (CFRXU) To Present At 27th Annual ROTH Conference     3/3/2015
Synthetic Biologics, Inc. (SYN) To Present At The 27th Annual ROTH Conference     3/3/2015
BioDelivery Sciences International (BDSI) To Present At The 27th Annual ROTH Conference     3/3/2015
Immune Pharmaceuticals, Inc. To Present At The Roth Conference     3/3/2015
CASI Pharmaceuticals  (ENMD) To Present At The 27th Annual ROTH Conference     3/3/2015
Stevia First Corp. To Present At The 27th Annual ROTH Capital Growth Conference     3/3/2015
MabVax Therapeutics, Inc. To Present At The 27th Annual Roth Conference     3/3/2015
DelMar Pharmaceuticals To Present At The 27th Annual ROTH Conference On March 10, 2015     3/3/2015
Depomed, Inc. (DEPO) To Present At 27th Annual Roth Conference     3/3/2015
Relmada Therapeutics To Present At ROTH Capital Partners 27th Annual Growth Stock Conference     3/3/2015
PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference     3/3/2015
Columbia Laboratories, Inc. (CBRX) To Present At The 27th Annual ROTH Conference     3/3/2015
BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015     3/3/2015
Ligand Pharmaceuticals Inc. (LGND) To Present At The 27th Annual Roth Conference On March 9th     3/3/2015
Verastem, Inc. (VSTM) To Present At 27th Annual ROTH Conference     3/3/2015
Foamix Pharmaceuticals, Ltd. (FOMX) To Present Corporate Overview At The Barclays Global Healthcare Conference     3/3/2015
Centene Corporation To Present At Barclays Global Healthcare Conference     3/3/2015
Ophthotech Corporation (OPHT) To Present At The Barclays Global Healthcare Conference     3/3/2015
Neurocrine Biosciences, Inc. (NBIX) To Present At The Barclays Global Healthcare Conference Live Audio Webcast Will Be On March 10, 2015     3/3/2015
Eli Lilly (LLY) To Participate In Barclays Global Healthcare Conference     3/3/2015
Esperion Therapeutics, Inc. (ESPR) To Present At Barclays Global Healthcare Conference     3/3/2015

Career Tips
HR Exec Reveals In-Demand Jobs at MyoKardia     2/19/2015
Pfizer (PFE) Buy Means Jobs: Make Sure Your References Are an Asset     2/19/2015
7 Job Search Sins     2/19/2015
5 Critical Reference Trends for 2015: Advice From HR Professionals     2/19/2015
5 Perfect Opportunities to Send a Thank You Note During Your Job Search     2/19/2015
Snag a Job: Here's How CSL Behring Makes Hiring Decisions     2/6/2015
Does Changing Ethnic Names on Resumes Improve Getting Hired?     2/5/2015
The One Empty Word to Avoid in a Job Interview     2/5/2015
10 Sure Things of a Successful Resume     2/5/2015
How to Create a Captivating Cover Letter     2/5/2015
Where Does Sanofi (SAN.PA) Find the Best Employees?     1/23/2015
Genentech (RHHBY) Reveals Their Greatest Source of Who They Hire     1/22/2015
6 Rules Every Biotech Job Seeker Should Know     1/22/2015
6 Things You Must Know When Working With Recruiters, HR, and Hiring Managers     1/22/2015
The Ultimate Secret of Acing Behavioral Interviews     1/22/2015

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->